Antimetastatic Activity of Gallic Acid‐conjugated Chitosan against Pulmonary Metastasis of Colon Carcinoma Cells

Abstract

We synthesized gallic acid (GA)‐conjugated chitosan (abbreviated as chitogallate) to study its antitumor activity against CT26 mouse colorectal carcinoma cells. GA was conjugated with chitosan by aid of water‐soluble carbodiimide. Chitogallate nanoparticles were prepared by dialysis method, and these nanoparticles have spherical shapes with sizes ranged about 70–250 nm. Chitogallate nanoparticles have superior antioxidants activities as well as GA itself. At cytotoxicity study, GA showed dose‐dependent cytotoxicities against CCD986sk cells and CT26 cells while chitogallate nanoparticles were not significantly affected to the viability of cells. In Matrigel invasion assay, chitogallate nanoparticles have superior anti‐invasive capacity against cancer cells as well as GA itself, i.e., invasiveness of CT26 cells was decreased according to GA contents in chitogallate nanoparticles. Furthermore, gelatin zymography also showed that chitogallate nanoparticles having higher substitution degree of GA decreased matrix metalloproteinase‐2 activity. Chitogallate nanoparticles efficiently inhibited pulmonary metastasis of CT26 cells in animal pulmonary metastasis model. We prepared chitogallate nanoparticles for application as an anti‐invasive agent. Chitogallate nanoparticles were less toxic than GA itself and have superior anti‐invasive/antimetastatic activity. We suggest that chitogallate nanoparticles are promising candidate for inhibition of tumor invasion/metastasis.

Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action

“…The GA-g-CS-CPP nanoparticles demonstrated powerful antioxidant activity and cytotoxicity against Caco-2 colon cancer cells, and the EGCG-loaded GA-g-CS-CPP nanoparticles further amplified the anticancer activity against Caco-2 cells (87). Similarly, GA-conjugated chitosan efficiently inhibited pulmonary metastasis of CT26 mouse colorectal carcinoma cells (88). In 1,2-dimethyl hydrazine-induced colon carcinogenesis in rats, the activity of phase II enzymes decreases, and phase I enzymes increases, whereas it is interesting to note that GA treatment could shift the above changes toward normal levels (89).…”

Gallic acid: design of a pyrogallol-containing hydrogel and its biomedical applications

“…198,199 Furthermore, polymers grafted with GA also exhibit antitumour activity. 200,201 One drawback of GA is its low bioavailability. To address this concern, nanoparticles that deliver GA have been developed for cancer treatment.…”

Chitin oligosaccharides for the food industry: production and applications

“…In recent years, the antitumor and anticancer properties of CHOS and COS have received extensive attention [204,205]. Studies have found that both of them have excellent preventive and therapeutic effects on colorectal cancer (CRC) [206], hepatocarcinoma [207], and pulmonary carcinoma [208], which determined their potential to be as functional foods against cancer.…”